MREO logo

Mereo BioPharma (MREO) Cash From Financing

Annual CFF

$7.97 M
+$7.77 M+3886.50%

December 31, 2023


Summary


Performance

MREO Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMREOcash flowmetrics:

Quarterly CFF

-$594.00 K
-$47.38 M-101.27%

September 30, 2024


Summary


Performance

MREO Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMREOcash flowmetrics:

TTM CFF

$46.19 M
-$8.50 M-15.54%

September 30, 2024


Summary


Performance

MREO TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMREOcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

MREO Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+3886.5%-101.3%-15.5%
3 y3 years-83.2%--
5 y5 years+402.8%--

MREO Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-92.4%+3886.5%-101.3%at low-15.5%>+9999.0%
5 y5-year-92.4%+206.5%-101.3%at low-15.5%>+9999.0%
alltimeall time-92.4%+206.5%-101.3%at low-15.5%>+9999.0%

Mereo BioPharma Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$594.00 K(-101.3%)
$46.19 M(-15.5%)
Jun 2024
-
$46.78 M(>+9900.0%)
$54.69 M(+585.9%)
Dec 2023
$7.97 M(+3886.5%)
$0.00(-100.0%)
$7.97 M(0.0%)
Sep 2023
-
$7.91 M(>+9900.0%)
$7.97 M(>+9900.0%)
Jun 2023
-
$67.00 K
$67.00 K
Dec 2022
$200.00 K(-99.8%)
-
-
DateAnnualQuarterlyTTM
Dec 2021
$104.80 M(+121.4%)
-
-
Dec 2020
$47.34 M(-732.3%)
-
-
Dec 2019
-$7.49 M(+184.3%)
-
-
Dec 2018
-$2.63 M(-105.8%)
-
-
Dec 2017
$45.60 M(-45.9%)
-
-
Dec 2016
$84.34 M
-
-

FAQ

  • What is Mereo BioPharma annual cash flow from financing activities?
  • What is the all time high annual CFF for Mereo BioPharma?
  • What is Mereo BioPharma annual CFF year-on-year change?
  • What is Mereo BioPharma quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Mereo BioPharma?
  • What is Mereo BioPharma quarterly CFF year-on-year change?
  • What is Mereo BioPharma TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Mereo BioPharma?
  • What is Mereo BioPharma TTM CFF year-on-year change?

What is Mereo BioPharma annual cash flow from financing activities?

The current annual CFF of MREO is $7.97 M

What is the all time high annual CFF for Mereo BioPharma?

Mereo BioPharma all-time high annual cash flow from financing activities is $104.80 M

What is Mereo BioPharma annual CFF year-on-year change?

Over the past year, MREO annual cash flow from financing activities has changed by +$7.77 M (+3886.50%)

What is Mereo BioPharma quarterly cash flow from financing activities?

The current quarterly CFF of MREO is -$594.00 K

What is the all time high quarterly CFF for Mereo BioPharma?

Mereo BioPharma all-time high quarterly cash flow from financing activities is $46.78 M

What is Mereo BioPharma quarterly CFF year-on-year change?

Over the past year, MREO quarterly cash flow from financing activities has changed by -$47.38 M (-101.27%)

What is Mereo BioPharma TTM cash flow from financing activities?

The current TTM CFF of MREO is $46.19 M

What is the all time high TTM CFF for Mereo BioPharma?

Mereo BioPharma all-time high TTM cash flow from financing activities is $54.69 M

What is Mereo BioPharma TTM CFF year-on-year change?

Over the past year, MREO TTM cash flow from financing activities has changed by -$8.50 M (-15.54%)